Haloperidol and Acute Pancreatitis
Haloperidol is not listed as a known cause of acute pancreatitis in the FDA drug label, and there is no substantial evidence linking it to pancreatic inflammation. When evaluating a patient on haloperidol who develops pancreatitis, you should pursue other more common etiologies first.
Evidence from FDA Drug Label
The official FDA prescribing information for haloperidol 1 does not list pancreatitis among its adverse effects. The drug label comprehensively details numerous side effects including:
- Neurological: Tardive dyskinesia, neuroleptic malignant syndrome, extrapyramidal symptoms
- Metabolic: Hyperglycemia, hypoglycemia, hyponatremia
- Gastrointestinal: Anorexia, constipation, diarrhea, nausea, vomiting
- Hepatic: Impaired liver function, jaundice
- Hematologic: Leukopenia, agranulocytosis (rare)
Notably absent from this extensive list is any mention of pancreatitis, which is significant given the thoroughness of adverse event reporting required by the FDA.
Context from Drug-Induced Pancreatitis Literature
Multiple comprehensive reviews of drug-induced pancreatitis have been published 2, 3, 4, 5, 6, with the most rigorous being the 2007 evidence-based classification system 4. This system categorizes drugs into four classes based on strength of evidence, with Class I requiring rechallenge data and Class II requiring consistent latency patterns in ≥75% of cases.
Haloperidol does not appear in any of these classification systems, including the extensive 2005 review that examined the top 100 prescription medications in the United States 5. The drugs consistently implicated in pancreatitis include azathioprine, valproic acid, didanosine, mesalamine, and thiazide diuretics—but not haloperidol.
Clinical Approach When Pancreatitis Occurs in a Patient on Haloperidol
When evaluating acute pancreatitis in a patient taking haloperidol, the UK guidelines 7 recommend systematic investigation:
Initial workup should focus on:
- Gallstone disease (accounts for ~50% of cases) - obtain at least two high-quality ultrasounds
- Alcohol intake history (20-25% of cases)
- Metabolic causes: fasting lipids, serum calcium
- Other medications the patient is taking
- Liver function tests
For recurrent idiopathic cases, consider:
- Endoscopic ultrasound for microlithiasis
- MRCP for ductal abnormalities
- Autoimmune markers
- Review of ALL medications, not just haloperidol
Important Caveat
While haloperidol itself is not associated with pancreatitis, be aware that other antipsychotics (particularly quetiapine) have been reported to cause pancreatitis 8, sometimes through metabolic derangements like hypertriglyceridemia. If your patient is on multiple psychotropic medications, scrutinize each one individually.
The diagnosis of idiopathic pancreatitis should not be accepted until a vigorous search for gallstones and other common causes has been completed 7. Do not prematurely attribute pancreatitis to haloperidol when more likely culprits remain uninvestigated.